AIM IMMUNOTECH INC. Proceeds from Sale of Investment Projects
AIM IMMUNOTECH INC. (AIM) reported Proceeds from Sale of Investment Projects of $5.62 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfInvestmentProjects · last filed 2025-03-27
- AIM IMMUNOTECH INC. proceeds from sale of investment projects for the quarter ending 2024-12-31 was $4.03M, a 973.60% increase year-over-year.
- AIM IMMUNOTECH INC. proceeds from sale of investment projects for the quarter ending 2024-09-30 was $492.00K, a 50.92% increase year-over-year.
- AIM IMMUNOTECH INC. proceeds from sale of investment projects for the quarter ending 2024-06-30 was $1.05M.
- AIM IMMUNOTECH INC. proceeds from sale of investment projects for the quarter ending 2024-03-31 was $50.00K, a 91.64% decline year-over-year.
- AIM IMMUNOTECH INC. proceeds from sale of investment projects for fiscal 2024 was $5.62M, a 332.87% increase from fiscal 2023.
- AIM IMMUNOTECH INC. proceeds from sale of investment projects for fiscal 2023 was $1.30M, a 87.12% decline from fiscal 2022.
- AIM IMMUNOTECH INC. proceeds from sale of investment projects for fiscal 2022 was $10.08M.
| Period end | Proceeds from Sale of Investment Projects 3 month | Proceeds from Sale of Investment Projects 6 month | Proceeds from Sale of Investment Projects 9 month | Proceeds from Sale of Investment Projects 12 month |
|---|---|---|---|---|
| 2024-12-31 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $4.52M derived: sum of 2 quarters · filed 2025-03-27 | $5.57M derived: sum of 3 quarters · filed 2025-03-27 | $5.62M 10-K · filed 2025-03-27 |
| 2024-09-30 | $492.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.55M derived: sum of 2 quarters · filed 2024-11-14 | $1.60M 10-Q · filed 2024-11-14 | $1.97M derived: sum of 4 quarters · filed 2025-03-27 |
| 2024-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.10M 10-Q · filed 2024-08-14 | $1.48M derived: sum of 3 quarters · filed 2025-03-27 | $1.81M derived: sum of 4 quarters · filed 2025-03-27 |
| 2024-03-31 | $50.00K 10-Q · filed 2024-05-15 | $425.00K derived: sum of 2 quarters · filed 2025-03-27 | $751.00K derived: sum of 3 quarters · filed 2025-03-27 | $751.00K derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-12-31 | $375.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $701.00K derived: sum of 2 quarters · filed 2025-03-27 | $701.00K derived: sum of 3 quarters · filed 2025-03-27 | $1.30M 10-K · filed 2025-03-27 |
| 2023-09-30 | $326.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $326.00K derived: sum of 2 quarters · filed 2024-11-14 | $924.00K 10-Q · filed 2024-11-14 | $1.93M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $598.00K 10-Q · filed 2024-08-14 | $1.60M derived: sum of 3 quarters · filed 2024-08-14 | |
| 2023-03-31 | $598.00K 10-Q · filed 2024-05-15 | $1.60M derived: sum of 2 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $10.08M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $9.08M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |